# Eyenovia MiDD Usability Study

> **NCT03480906** · NA · COMPLETED · sponsor: **Eyenovia Inc.** · enrollment: 30 (actual)

## Conditions studied

- Intraocular Pressure

## Interventions

- **DRUG:** Latanoprost
- **DRUG:** Latanoprost

## Key facts

- **NCT ID:** NCT03480906
- **Lead sponsor:** Eyenovia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-12
- **Primary completion:** 2018-03-17
- **Final completion:** 2018-03-17
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480906, "Eyenovia MiDD Usability Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03480906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*